Zacks Investment Research upgraded shares of HealthStream (NASDAQ:HSTM) from a sell rating to a hold rating in a research note issued to investors on Wednesday morning.
According to Zacks, “HealthStream is dedicated to improving patient outcomes through the development of healthcare organizations’ greatest asset: their people. Their unified suite of solutions is contracted by, collectively, over 4.5 million healthcare employees in the U.S. for workforce development, training & learning management, talent management, performance assessment, and managing simulation-based education programs. Their research solutions provide valuable insight to healthcare providers to meet HCAHPS requirements, improve the patient experience, engage their workforce, and enhance physician alignment. Their provider solutions offer healthcare providers innovative tools to support healthcare organizations in appropriately credentialing and privileging their workforce. “
Several other research analysts have also issued reports on HSTM. ValuEngine lowered HealthStream from a hold rating to a sell rating in a research report on Monday. BidaskClub lowered HealthStream from a hold rating to a sell rating in a research report on Wednesday, January 31st. Robert W. Baird dropped their target price on HealthStream from $30.00 to $28.00 and set an outperform rating for the company in a research report on Wednesday, October 25th. Needham & Company LLC lowered HealthStream from a buy rating to a hold rating in a research report on Wednesday, October 25th. Finally, Canaccord Genuity restated a hold rating and set a $25.00 target price on shares of HealthStream in a research report on Monday, October 23rd. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. HealthStream currently has a consensus rating of Hold and a consensus target price of $24.83.
Several large investors have recently made changes to their positions in HSTM. Stevens Capital Management LP bought a new stake in shares of HealthStream during the third quarter valued at approximately $367,000. BNP Paribas Arbitrage SA raised its stake in shares of HealthStream by 65.6% during the third quarter. BNP Paribas Arbitrage SA now owns 13,466 shares of the technology company’s stock valued at $315,000 after acquiring an additional 5,335 shares in the last quarter. Cornerstone Capital Management Holdings LLC. bought a new stake in shares of HealthStream during the third quarter valued at approximately $448,000. Algert Global LLC bought a new stake in shares of HealthStream during the third quarter valued at approximately $1,948,000. Finally, Northern Trust Corp raised its stake in shares of HealthStream by 6.1% during the second quarter. Northern Trust Corp now owns 468,703 shares of the technology company’s stock valued at $12,337,000 after acquiring an additional 27,080 shares in the last quarter. Institutional investors and hedge funds own 75.02% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This article was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.com-unik.info/2018/02/08/healthstream-hstm-stock-rating-upgraded-by-zacks-investment-research.html.
HealthStream Company Profile
HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.